AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.27B |
| 2 |
Visa
V
|
+$459M |
| 3 |
Nike
NKE
|
+$410M |
| 4 |
Etsy
ETSY
|
+$311M |
| 5 |
Gen Digital
GEN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$606M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$492M |
| 3 |
Procter & Gamble
PG
|
+$389M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$310M |
| 5 |
IQVIA
IQV
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.23% |
| 2 | Healthcare | 14.38% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 12.81% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
CytomX Therapeutics
CTMX
$675M
| $361K | ﹤0.01% |
57,100
+10,300
| +22% | +$80.2K |
|
|
BCOV
2952
DELISTED
Brightcove, Inc.
BCOV
| $360K | ﹤0.01% |
25,100
-8,100
| -24% | -$130K |
|
2953
Alpha and Omega Semiconductor
AOSL
$950M
| $359K | ﹤0.01% |
11,800
| – | – |
|
2954
Cooper-Standard Automotive
CPS
$523M
| $359K | ﹤0.01% |
12,380
| – | – |
|
2955
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
| $359K | ﹤0.01% |
3,406
-13
| -0.4% | -$1.36K |
|
|
MRNS
2956
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $359K | ﹤0.01% |
20,024
+2,000
| +11% | +$32.2K |
|
|
CGC
2957
Canopy Growth
CGC
$387M
| $358K | ﹤0.01% |
1,481
| – | – |
|
2958
Cullinan Oncology
CGEM
$1.01B
| $355K | ﹤0.01% |
+13,800
| New | +$424K |
|
2959
Vanguard Russell 2000 ETF
VTWO
$17.3B
| $355K | ﹤0.01% |
3,831
-27
| -0.7% | -$2.45K |
|
|
AUD
2960
DELISTED
Audacy, Inc.
AUD
| $354K | ﹤0.01% |
82,100
-9,600
| -10% | -$44.1K |
|
2961
Insteel Industries
IIIN
$593M
| $351K | ﹤0.01% |
10,917
-900
| -8% | -$31.1K |
|
2962
Johnson Outdoors
JOUT
$491M
| $351K | ﹤0.01% |
2,900
+600
| +26% | +$80.4K |
|
2963
Entravision Communication
EVC
$1.03B
| $350K | ﹤0.01% |
52,400
-2,900
| -5% | -$13.1K |
|
2964
Capital City Bank Group
CCBG
$888M
| $347K | ﹤0.01% |
13,444
-1,600
| -11% | -$41.5K |
|
2965
Olema Pharmaceuticals
OLMA
$1B
| $347K | ﹤0.01% |
+12,400
| New | +$353K |
|
2966
Central Garden & Pet Co
CENT
$2.69B
| $342K | ﹤0.01% |
8,088
-875
| -10% | -$39.2K |
|
2967
Clearwater Paper
CLW
$339M
| $341K | ﹤0.01% |
11,788
| – | – |
|
2968
PureCycle Technologies
PCT
$1.28B
| $341K | ﹤0.01% |
+14,400
| New | +$310K |
|
2969
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
| $339K | ﹤0.01% |
2,946
-18,201
| -86% | -$2.09M |
|
2970
Digi International
DGII
$2.63B
| $336K | ﹤0.01% |
16,697
| – | – |
|
2971
Hyster-Yale Materials Handling
HY
$599M
| $336K | ﹤0.01% |
4,598
-1,500
| -25% | -$116K |
|
2972
QCR Holdings
QCRH
$1.69B
| $334K | ﹤0.01% |
6,939
-1,400
| -17% | -$66.9K |
|
2973
Comtech Telecommunications
CMTL
$50.3M
| $333K | ﹤0.01% |
13,790
-2,647
| -16% | -$64.6K |
|
2974
Horizon Bancorp
HBNC
$1.04B
| $329K | ﹤0.01% |
18,878
-4,000
| -17% | -$73K |
|
2975
Vishay Precision Group
VPG
$1.22B
| $327K | ﹤0.01% |
9,619
-1,828
| -16% | -$60.7K |
|
Similar funds
AllianceBernstein's Q2 2021 Portfolio in Review
As of Q2 2021, AllianceBernstein held 3,558 positions worth $249B, up 9.2% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AllianceBernstein's Q2 2021 filing shows 327 new, 1,436 increased, 1,300 reduced and 241 closed positions. Its largest new stake was Coinbase: 547,649 shares worth $139M. The largest sale was Regeneron Pharmaceuticals, an estimated $606M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q2 2021 buy was Coinbase: 547,649 shares worth $139M.
- AllianceBernstein added most to Amazon in Q2 2021, an estimated $1.27B increase.
- AllianceBernstein's biggest Q2 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $606M.
- AllianceBernstein fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $43.3M.
- AllianceBernstein's ten largest holdings make up 24% of its $249B portfolio in Q2 2021.
- AllianceBernstein opened 327 new positions and closed 241 in Q2 2021.
- AllianceBernstein's portfolio value rose 9.2% quarter-over-quarter to $249B.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.